针对局限性摄护腺癌患者关于RP与WW的利弊，目前已有的临床试验无法提供足够的证据而能有可信的声明。
The existing trials provide insufficient evidence to allow confident statements to be made about the relative beneficial and harmful effects of RP and WW for patients with localised prostate cancer.
针对局限性摄护腺癌患者关于RP与WW的利弊，目前已有的临床试验无法提供足够的证据而能有可信的声明。
The existing trials provide insufficient evidence to allow confident statements to be made about the relative beneficial and harmful effects of RP and WW for patients with localised prostate cancer.
应用推荐